Citadel Advisors
CNSY

Citadel Advisors’s Cerenome CNSY Stock Holding History

Citadel Advisors’s Portfolio CNSY Stock Details CNSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Hold
0
– -$25K – 7941
2017
Q1 		– Hold
0
– – – 7203
2016
Q4 		– Hold
0
– – – 7051
2016
Q1 		– Hold
0
– -$3K – 7719
2015
Q4 		– Hold
0
– – – 8539
2015
Q3 		– Hold
0
– – – 8633
2015
Q1 		– Hold
0
– -$1K – 8781
2014
Q4 		– Hold
0
– – – 8417
2014
Q3 		– Hold
0
– – – 7917
2014
Q2 		– Hold
0
– – – 7696
2014
Q1 		– Hold
0
– – – 7517
2013
Q4 		– Hold
0
– – – 6822
2013
Q3 		– Hold
0
– – – 6007
2013
Q2 		– Hold
0
– – – 5955

Other funds holding CNSY

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM

Citadel Advisors's CNSY Position: Q2 2026 in Review

Citadel Advisors opened a new position in Cerenome (CNSY) in Q2 2026: 25,597 shares worth $112K. The stake represents ﹤0.01% of the portfolio and ranks #12605 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in CNSY as recently as Q4 2025.

Citadel Advisors first reported a position in CNSY in Q1 2019 and has held it in 13 quarters since. 21 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

  • Citadel Advisors held 25,597 shares of Cerenome worth $112K as of Q2 2026.
  • Cerenome was a new Citadel Advisors position in Q2 2026.
  • Cerenome made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12605 holding.
  • Citadel Advisors first reported a position in Cerenome in Q1 2019 and has held it in 13 quarters since.
  • 21 funds tracked by Wall St. Rank held Cerenome as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.